Mr. Wood
Banned
- Joined
- Oct 4, 2013
- Messages
- 26,961
- Reaction score
- 5,127
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases
Aug 19, 2020
who cud hav seen momenta being acquired?
Aug 19, 2020
$6.5 Billion Acquisition Through an All-Cash Tender Offer of $52.50 Per Momenta Share
This acquisition provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson to broaden its leadership in immune-mediated diseases and drive further growth through expansion into autoantibody-driven disease. The transaction will include full global rights to nipocalimab (M281), a clinically validated, potentially best-in-class anti-FcRn antibody.
who cud hav seen momenta being acquired?

